Threshold Pharmaceuticals Announces Preclinical Data Presentations on Tarloxotinib at the 2015 AACR-NCI-EORTC Meeting
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/27/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that it will present preclinical data on tarloxotinib bromide*, or "tarloxotinib", in two scientific posters at the AACR-NCI- …